Key points:
·A man in Sydney, Australia, is suspected of selling e-liquid containing synthetic opioids.
·Police seized 2.1 kilograms of synthetic opioids, which are highly addictive and potentially fatal.
·Experts recommend carrying naloxone to prevent overdose.
【2Firsts News Flash】According to a report from ABC on August 6th, a man in Sydney, Australia has become the first person to be charged with allegedly supplying the substance "nitazene" in e-liquid, which is used in vaping products.
After conducting an investigation, the New South Wales police claimed that a 20-year-old man had cleverly operated a sophisticated illegal drug distribution scheme from March to July 2025, responsible for supplying nitrazepam-like substances in e-liquids.
On August 1st, police raided a residence, allegedly discovering e-cigarette devices, small bottles of liquid, and over 7000 Australian dollars (approximately 4542 US dollars) in cash. Additionally, police also found two imitation firearms, a stun gun, and a locked safe, which they were unable to open on site.
The police later opened the safe and found 1.8 kilograms of methylenedioxymethamphetamine (MDMA), bringing the total amount seized to 2.1 kilograms. The suspect was arrested at the scene and charged with illegally selling drugs and knowingly handling proceeds from criminal activities.
Police have pointed out that the man is involved in the sale, preparation, and distribution of e-liquid. In a statement, Commander John Watson, of the Narcotics and Firearms Unit, stated that Nitrazepam substances are highly addictive and potentially lethal.
Detective Watson stated that this incident represents a "disturbing evolution" in drug trafficking, alleging that suppliers are manufacturing user dependency by adding these synthetic opioids to e-liquids, ensuring repeat purchases in the future.
According to the New South Wales Department of Health, Nitazene substances are a highly potent synthetic opioid drug that is more likely to cause respiratory failure than other opioids. Authorities have stated that the potency of these drugs may be hundreds of times that of heroin.
Addiction expert Dr. Hester Wilson has warned about the dangers of synthetic opioids, stating that symptoms of overdose include pinpoint pupils, drowsiness, loss of consciousness, slow or shallow breathing, and blue or gray skin. She also advised anyone using recreational drugs to carry naloxone, a life-saving measure that can temporarily reverse the effects of an opioid overdose.
According to publicly available information, nitazene substances are a type of potent synthetic opioid drugs that have been identified as new psychoactive substances (NPS) in multiple countries in recent years. They possess extremely powerful pain-relieving abilities and carry a high risk of lethality.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
